Targeted Drugs Flashcards
What is the use of mAb drug contingent upon. Why?
- Test for the Presence of the Target on the Cancer
why:
- Must test because these targets are present on normal tissues too. For the drug to kill the tumor before killing the patient, the tumor must overexpress the receptor
What 3 general types of mAb drugs are there?
Naked - nothing else attached to them
Conjugated - carry a toxic agent
Bispecific - bring immune cells into proximity with cancer cells
CD20 specific mAbs
- Name Them.
- MOA
- Adverse Effects
- Administration
Rituximab, Ofatumumab
MOA:
binds CD20 having 2 effects:
1) CD20 stimulation triggers Apoptotic Pathway
2) IgG can Fix Complement with Fc region
Adverse Effects:
This causes B cell Depletion
Administration:
- IV or SubQ
Diseases Treated with CD20 drugs.
- Name Drugs
Rituximab:
- Chronic Lymphocytic Leukemia (CLC)
- Non-Hodgkin’s Lymphoma (NHL)
Ofatumumab:
- CLL
CTLA-4 specific mAb
- Name.
- MOA
- Administration
Ipilimumab
MOA:
- Immunostimulant binds CTLA-4 blocking CD80/CD86 from binding allos T cells to proliferated because no Treg suppression
Administration:
- IV or SubQ
Disease treated with Ipilimumab.
- what target it is specific for?
Melanoma
- CTLA-4 blocking Treg peripheral tolerance mechanism
EGFR drugs (not including Her-2 drugs)
- Name Them
- MOA
- Administration
Cetuximab and Panitumumab
MOA:
- Bind causing Apoptosis or ADCC
Administration:
- IV or SubQ
What is the adverse effect of the EGFR drugs INCLUDING the HER-2 drugs?
- NAME all of these.
ALL:
- Photosensitivity
Her-2 specifically:
- Cardiac Toxicity
EGFR:
- Cetuximab
- Panitumumab
Her-2:
- Tratuzumab
- Pertuzumab
Her-2 Drugs
- Name them.
- MOA
- Administration
Traztuzumab and Pertuzumab
MOA:
Traztuzumab
- Inhibits Stimulatory Signal by binding HER-2 causing a downregulation of HER-2 and ACCUMULATION OF p-27 causing cell cycle arrest.
- Also apoptosis, ADCC
Pertuzumab:
- Blocks Heterodimerization of HER-2 and HER-3
Administration:
- IV or SubQ
EGFR drugs (including Her-2 drugs):
- Cancer Treated
- NAME THEM.
EGFR:
Cetuximab - colorectal, Head and Neck (H and N)
Panitumumab - Colorectal
Her-2: (traztumab, Pertuzumab)
Both treat breast cancer
VEGF drugs
- MOA
- Toxicity
- Delivery
Bevicizumab
MOA:
- Anti-Angiogenesis
Toxicity:
- Cardiac
- Pulmonary
- GI perforation
Delivery:
- IV or SubQ
What types of cancer are treated with VEGF inhibitors?
- Name the drug.
- Colorectal
- Non-small cell lung carcinoma (NSCLC)
- Large solid tumors
Bevicizumab
Why is VEGF and effective target for large tumors?
Large tumors get hypoxic and need more BVs:
- HIF-1alpha unbinds from VHF which usually targets HIF-1alpha to the 26S proteasome
- Free HIF-1alphs is then able to translate the nucleus and upregulate VEGF signaling
Are mAb drugs ever given orally?
- No they would degrade rapidly in the stomach
Penetrance into the tumor is vital to fighting it. How are mAbs engineered so that they’re better equipped to penetrate?
Fc regions are often removed
How are mAb drugs metabolized and why is this an advantage?
- what can we do to slow down degradation in these?
- Broken down by Lysosomal and Cytosolic processes
- No CYP or Hepatic metabolism means no drug-drug interactions
- mAbs can be formulated with PEG to prevent renal secretion
Besides adding PEG how is the half life of mAbs extended intrinsically?
- where is this receptor found usually?
- FcRn (fetal Brambell receptor)
- FcRn Receptor is found on the surface of Adult epithelial cells and monocytes (these cells bind the Fc region, endocytose, then recycle the mAb)
What are some of the general adverse effects of mAbs?
- Anaphylaxis, Angioedema, Pulmonary Toxicity
- Depletions of Cell populations that express the same target as the tumor
What mAb drug causes increased oxidative stress in cardiac myocytes and cadiotoxicity?
- what is the intended target of this drug?
- Trastuzumab [Herceptin] blocks HER2 activity
- Intended target is Breast Cancer Tissue, but Cardiac Myoctyes also express Her-2 so they get targeted too.
What mAb drug causes HTN, proteinuria, and thrombotic microangiopathy?
- explain why?
- what is the intended target of this drug?
Bevacizumab [avastin]
- These are sides effects caused by Bevacizumab disrupting RENAL HOMOSTASIS
- Intended target of Bevacizumab is VEGF
What mAb causes renal magnesium wasting and hypomagnesemia via effects on the distal convoluted tubule?
Cetuximab [Erbitux]
What mAbs work as checkpoint inhibitors to improve immune response to tumor cells?
- what is their target?
- idea behind these drugs?
CTLA-4 binding drugs:
- Ipilumumab - prevents CTLA-4 from binding B7 (CD80/86)
PD1 binding drugs:
- Nivolumab
- Pemmbolizumab
- Prevents PD1 from repressing activation of T cells in 2˚ lymph tissue
What is a common cancer treated by the checkpoint inhibiting drugs?
- NAME these drugs.
melanoma
- Ipilumumab
- Nivolumab
- Pemmbolizumab